FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128906677> ?p ?o ?g. }

• W3128906677 endingPage "1065" @default.
• W3128906677 startingPage "1057" @default.
• W3128906677 abstract "Abstract Purpose This review describes and analyzes literature to provide recommendations for use of extended-duration thromboprophylaxis (EDT) in medically ill patients. Summary Guidelines recommend pharmacologic thromboprophylaxis for patients at increased thrombosis risk during hospitalization and recommend against extending thromboprophylaxis beyond hospitalization. Despite these recommendations, observational data demonstrate that venous thromboembolism (VTE) risk persists following hospital discharge. A MEDLINE literature search was performed to identify original research evaluating the safety and efficacy of EDT. Eight meta-analyses and 5 randomized controlled trials—each varying in the agents studied (enoxaparin, rivaroxaban, apixaban, and betrixaban)—were selected for inclusion. Collectively, the evaluated data demonstrates that EDT reduces the incidence of VTE at the expense of increasing the risk of major bleeding and without providing mortality reduction. Variations in enrollment criteria, differences in EDT strategies, and uncertainty regarding proper patient selection limit the applicability of EDT in practice. Rivaroxaban and betrixaban gained Food and Drug Administration (FDA) approval on the basis of results of the APEX and MARINER trials and a post hoc analysis of the MAGELLEN trial results. Although a number of agents are FDA approved for use in EDT, clinicians must carefully weigh the risks vs benefits of EDT with these agents until studies demonstrate a more favorable risk-benefit profile. Conclusion Evidence to support EDT in medically ill patients is inconclusive and has highlighted the need for an individualized approach. The reviewed evidence supports guideline recommendations from both the American College of Chest Physicians and the American Society of Hematology that recommend against routine use of EDT in the majority of medically ill patients. Future studies are needed to optimize the risk-benefit profile of EDT and to ensure proper patient selection." @default.
• W3128906677 created "2021-02-15" @default.
• W3128906677 creator A5015735286 @default.
• W3128906677 creator A5043315085 @default.
• W3128906677 creator A5052734040 @default.
• W3128906677 creator A5064412189 @default.
• W3128906677 creator A5083133117 @default.
• W3128906677 date "2021-02-13" @default.
• W3128906677 modified "2023-09-27" @default.
• W3128906677 title "A clinical focus on the use of extended-duration thromboprophylaxis in medically ill patients" @default.
• W3128906677 cites W1511757448 @default.
• W3128906677 cites W1992300775 @default.
• W3128906677 cites W2041927436 @default.
• W3128906677 cites W2062202481 @default.
• W3128906677 cites W2109813202 @default.
• W3128906677 cites W2110992040 @default.
• W3128906677 cites W2117983655 @default.
• W3128906677 cites W2118615533 @default.
• W3128906677 cites W2119231181 @default.
• W3128906677 cites W2132381095 @default.
• W3128906677 cites W2143062318 @default.
• W3128906677 cites W2148287985 @default.
• W3128906677 cites W2155526932 @default.
• W3128906677 cites W2159407715 @default.
• W3128906677 cites W2162499932 @default.
• W3128906677 cites W2294236942 @default.
• W3128906677 cites W2313923699 @default.
• W3128906677 cites W2340796010 @default.
• W3128906677 cites W2407139997 @default.
• W3128906677 cites W2538428595 @default.
• W3128906677 cites W2557341155 @default.
• W3128906677 cites W2561416754 @default.
• W3128906677 cites W2577110809 @default.
• W3128906677 cites W2770158757 @default.
• W3128906677 cites W2791362705 @default.
• W3128906677 cites W2888169160 @default.
• W3128906677 cites W2902174064 @default.
• W3128906677 cites W2942896969 @default.
• W3128906677 cites W2949692888 @default.
• W3128906677 cites W2955265120 @default.
• W3128906677 cites W2982809361 @default.
• W3128906677 cites W2990226564 @default.
• W3128906677 cites W3016782834 @default.
• W3128906677 doi "https://doi.org/10.1093/ajhp/zxab039" @default.
• W3128906677 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33580664" @default.
• W3128906677 hasPublicationYear "2021" @default.
• W3128906677 type Work @default.
• W3128906677 sameAs 3128906677 @default.
• W3128906677 citedByCount "0" @default.
• W3128906677 crossrefType "journal-article" @default.
• W3128906677 hasAuthorship W3128906677A5015735286 @default.
• W3128906677 hasAuthorship W3128906677A5043315085 @default.
• W3128906677 hasAuthorship W3128906677A5052734040 @default.
• W3128906677 hasAuthorship W3128906677A5064412189 @default.
• W3128906677 hasAuthorship W3128906677A5083133117 @default.
• W3128906677 hasConcept C126322002 @default.
• W3128906677 hasConcept C141071460 @default.
• W3128906677 hasConcept C142724271 @default.
• W3128906677 hasConcept C168563851 @default.
• W3128906677 hasConcept C17744445 @default.
• W3128906677 hasConcept C177713679 @default.
• W3128906677 hasConcept C194828623 @default.
• W3128906677 hasConcept C199539241 @default.
• W3128906677 hasConcept C23131810 @default.
• W3128906677 hasConcept C2776301958 @default.
• W3128906677 hasConcept C2778661090 @default.
• W3128906677 hasConcept C2778810321 @default.
• W3128906677 hasConcept C2779161974 @default.
• W3128906677 hasConcept C2779473830 @default.
• W3128906677 hasConcept C2780182762 @default.
• W3128906677 hasConcept C2780638905 @default.
• W3128906677 hasConcept C2780868729 @default.
• W3128906677 hasConcept C2991741193 @default.
• W3128906677 hasConcept C535046627 @default.
• W3128906677 hasConcept C71924100 @default.
• W3128906677 hasConceptScore W3128906677C126322002 @default.
• W3128906677 hasConceptScore W3128906677C141071460 @default.
• W3128906677 hasConceptScore W3128906677C142724271 @default.
• W3128906677 hasConceptScore W3128906677C168563851 @default.
• W3128906677 hasConceptScore W3128906677C17744445 @default.
• W3128906677 hasConceptScore W3128906677C177713679 @default.
• W3128906677 hasConceptScore W3128906677C194828623 @default.
• W3128906677 hasConceptScore W3128906677C199539241 @default.
• W3128906677 hasConceptScore W3128906677C23131810 @default.
• W3128906677 hasConceptScore W3128906677C2776301958 @default.
• W3128906677 hasConceptScore W3128906677C2778661090 @default.
• W3128906677 hasConceptScore W3128906677C2778810321 @default.
• W3128906677 hasConceptScore W3128906677C2779161974 @default.
• W3128906677 hasConceptScore W3128906677C2779473830 @default.
• W3128906677 hasConceptScore W3128906677C2780182762 @default.
• W3128906677 hasConceptScore W3128906677C2780638905 @default.
• W3128906677 hasConceptScore W3128906677C2780868729 @default.
• W3128906677 hasConceptScore W3128906677C2991741193 @default.
• W3128906677 hasConceptScore W3128906677C535046627 @default.
• W3128906677 hasConceptScore W3128906677C71924100 @default.
• W3128906677 hasIssue "12" @default.
• W3128906677 hasLocation W31289066771 @default.
• W3128906677 hasOpenAccess W3128906677 @default.

• next